Revolutionizing Heart Health: The SCAPIS Study Aims to Predict and Prevent Heart Attacks
Approximately 8,000 individuals under the age of 70 experience a first-time heart attack each year, with over 1,000 of those cases resulting in death. Dr. Göran Bergström, the chief physician at Sahlgrenska University Hospital in Gothenburg, emphasizes the goal of reducing this number significantly by the year 2030.
Dr. Bergström is not only dedicated to direct patient care; he also plays a leading role in SCAPIS (Swedish Cardio Pulmonary Bioimage Study), the world's largest research initiative focused on heart vessels and lungs. The study, a collaborative effort involving six universities and university hospitals, aims to analyze 30,000 residents to better understand and ultimately prevent heart and lung diseases.
"My focus is on identifying seemingly healthy individuals who may be at risk for a heart attack without any visible symptoms," explains Dr. Bergström. "It is critically important to develop tools that can help pinpoint these at-risk individuals. SCAPIS is therefore incredibly significant."
Out of the 30,000 participants in the study, researchers are particularly looking for changes in the blood vessels that may suggest a heightened risk for heart attacks. Alarmingly, more than 40 percent of those examined showed variations in their heart's blood vessels. While most exhibited minor changes, one in every twenty individuals had more severe alterations—without any prior knowledge of their condition.
Dr. Bergström emphasizes that identifying these patients—albeit costly—is crucial. Current research is underway to develop cost-effective screening methods, such as identifying at-risk individuals with a simple blood test. "If we can identify these individuals early, we can provide preventive measures to avert a heart attack, primarily through lifestyle changes and effective medications. However, we must first locate these individuals," he adds.
A significant breakthrough could be achieved if the SCAPIS study results in a straightforward method for identifying high-risk individuals. Dr. Bergström envisions a blood test that is both accurate and affordable, aiming to detect and subsequently reduce the at-risk population by 20-30 percent by 2030.
Conducting research on such a grand scale comes with substantial costs. The Heart-Lung Foundation serves as the primary funding body for the SCAPIS initiative. "Every penny counts when it comes to advancing our research and making new discoveries, which is why we are seeking continued support," states Dr. Bergström.
While the study has the potential to measure a diverse array of factors in the blood, financial constraints currently limit their capacity to test everything they would like. Nevertheless, Dr. Bergström remains hopeful that innovative solutions will soon emerge, contingent on securing additional funding.
Thus, individuals interested in supporting the SCAPIS initiative and contributing to heart health advancements are encouraged to consider donations, such as a simple swish of 50 SEK. Every contribution can make a significant impact in the fight against heart disease and help save lives before the onset of heart attacks.
Related Sources: